OPKO Health, Inc.
OPK · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.04 | -0.01 | 0.01 | -0.48 |
| FCF Yield | -3.14% | -9.78% | -3.39% | -4.25% |
| EV / EBITDA | 15.59 | -14.61 | -34.04 | 17.01 |
| Quality | ||||
| ROIC | 3.84% | -3.00% | -3.16% | -0.66% |
| Gross Margin | 46.99% | 31.50% | 28.42% | 46.10% |
| Cash Conversion Ratio | -1.60 | 0.56 | 0.51 | -3.17 |
| Growth | ||||
| Revenue 3-Year CAGR | -9.52% | -8.54% | -8.92% | -10.78% |
| Free Cash Flow Growth | 56.42% | -129.69% | 24.23% | 41.40% |
| Safety | ||||
| Net Debt / EBITDA | -0.36 | -1.79 | -1.65 | 0.99 |
| Interest Coverage | 4.23 | -0.85 | -4.34 | -2.33 |
| Efficiency | ||||
| Inventory Turnover | 1.24 | 1.62 | 1.68 | 1.74 |
| Cash Conversion Cycle | 71.94 | 85.34 | 61.59 | 83.36 |